Dr Sonia Buist, Oregon Health & Science University, Oregon, USA and colleagues did a study of 9,425 people aged 40 years and over from 12 different countries around the world (the BOLD study). They found that the prevalence of stage II or higher COPD, as confirmed by spirometry testing, was 10.1% overall, broken down into 11.8% for men and 8.5% for women. A recent careful meta-analysis of COPD prevalence studies reported the incidence of stage II COPD to be 4.3%. The authors say: “Our estimates of the overall prevalence and staging of COPD are consistently higher than these figures, which accord with claims that COPD has generally been underestimated in the past.”
The authors add that the growing COPD burden is partly due to the aging population (with risk nearly doubling for every 10 years over the age of 40), and partly due to continuing use of tobacco, which is the most important risk factor. The variation in COPD prevalence between men and women is due mostly to differences in smoking habits. There were wide variations of COPD in the 12 worldwide sites, with Cape Town, South Africa recording the highest prevalence of combined stage II and III (men 22.2%, women 16.7%), and Hannover, Germany recording the lowest prevalence (men 8.6%, women 3.7%). The authors suggest the high rates in South Africa could be due to very high reported levels of previous tuberculosis and additional occupational exposures.
The authors conclude: “Although smoking cessation is becoming an increasingly urgent objective for an aging worldwide population, a better understanding of other factors that contribute to COPD is crucial to assist local public-health officials in developing the best possible primary and secondary prevention policies for their regions.”
In an accompanying Comment, Dr Emiel Wouters, Department of Respiratory Medicine, University Hospital Maastricht, Netherlands, says: “With quantitative data already available, it is already clear that COPD is a major disease worldwide. Recognition of this fact obligates us to make efforts towards increasing public awareness and efforts toward the adoption of an integrated approach aimed at reducing or stabilising the present and future burden of disease generated by COPD.”
In a related Review, Dr Buist and Dr David Mannino, University of Kentucky College of Public Health, Lexington, Kentucky, USA look at risk factors, prevalence and future trends of COPD. They say: "Worldwide, tobacco smoke remains the most important cause of COPD." WHO estimates that in high-income countries, 73% of COPD mortality is related to smoking, with 40% related to smoking in nations of low and middle income. They add: "Furthermore, smoking during pregnancy can negatively affect fetal lung growth and result in development of lung disease."Ageing is also a risk factor for COPD, with lung function starting to decline from its peak in young adulthood to lower levels in later life. The authors
say: "In looking to the future, one cannot ignore the changing demographics of the world's population and the reality that COPD is a disease of ageing." Such is the effect of the world's aging population on COPD prevalence, that the authors say: "Furthermore, if every smoker in the world were to stop smoking today, the rates of COPD would probably continue to increase for the next 20 years." The effects of occupational dust, vapours and fumes, infections, and asthma are also studied in the Review.
The authors conclude: "The challenge we will all face in the next few years will be implementation of cost-effective prevention and management strategies to stem the tide of this disease and its cost."
Tony Kirby | alfa
NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases
Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.
Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...
16.03.2018 | Event News
13.03.2018 | Event News
08.03.2018 | Event News
16.03.2018 | Earth Sciences
16.03.2018 | Physics and Astronomy
16.03.2018 | Life Sciences